MAGEA4 and esophageal cancer: The growth of MAGE-A4-expressing esophageal cancer was hindered in NOG mice through the use of genetically engineered T cells that expressed a MAGE-A4-specific TCR designed to target the MAGE-A4 143-151 peptide-NYKRCFPVI, which is restricted to HLA-A24 (87).